Tools | Bookmark & Share | Make MrWhy My Homepage
MrWhy.com
Go
MrWhy.com » Videos » Prof Luca Gianni - Fondazione IRCCS Istituto Tumori di Milano, Italy
Prof Luca Gianni - Fondazione IRCCS Istituto Tumori di Milano, Italy
Prof Luca Gianni - Fondazione IRCCS Istituto Tumori di Milano,  Italy
Report
Prof Luca Gianni - Fondazione IRCCS Istituto Tumori di Milano, Italy
The combination of pertuzumab and trastuzumab had superior antitumor activity in women with early HER2-positive breast cancer, according to Phase II study results of the NeoSphere neoadjuvant trial.Details of these study results were presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12, 2010.
Channel: www.ecancer.tv
Category: Science
Video Length: 0
Date Found: January 18, 2011
Date Produced:
View Count: 0
 
MrWhy.com Special Offers
1
2
3
4
5
 
About Us: About MrWhy.com | Advertise on MrWhy.com | Contact MrWhy.com | Privacy Policy | MrWhy.com Partners
Answers: Questions and Answers | Browse by Category
Comparison Shopping: Comparison Shopping | Browse by Category | Top Searches
Shop eBay: Shop eBay | Browse by Category
Shop Amazon: Shop Amazon | Browse by Category
Videos: Video Search | Browse by Category
Web Search: Web Search | Browse by Searches
Copyright © 2011 MrWhy.com. All rights reserved.